drugset / Trial / NCT03101722

Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD)

NCT03101722

Enrolling by invitation 60 enrolled Zhijun Bao
RandomizedParallel-groupSingle-blindTreatment

Summary

To investigate the effects of huperzine A on tinnitus suppression, hearing and cognitive function protection in patients with presbycusis-related subjective tinnitus and cognitive impairment.

Timeline

Start
2017-05-15
Primary completion
2030-09-15
Completion
2030-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Huperzine A Traditional medicine (herbal / TCM) 0.2 mg